Tirzepatide is a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://joycegqtn696314.slypage.com/41117656/tirzepatide-a-new-frontier-in-diabetes-treatment